Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
Marek, M., Shaik, T.B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., Schmidtkunz, K., Suzuki, T., Holl, R., Ennifar, E., Pierce, R.J., Jung, M., Sippl, W., Romier, C.(2018) J Med Chem 61: 10000-10016
- PubMed: 30347148 
- DOI: https://doi.org/10.1021/acs.jmedchem.8b01087
- Primary Citation of Related Structures:  
6HQY, 6HRQ, 6HSF, 6HSG, 6HSH, 6HSK, 6HSZ, 6HT8, 6HTG, 6HTH, 6HTI, 6HTT, 6HTZ, 6HU0, 6HU1, 6HU2, 6HU3 - PubMed Abstract: 
Metal-dependent histone deacetylases (HDACs) are key epigenetic regulators that represent promising therapeutic targets for the treatment of numerous human diseases. Yet the currently FDA-approved HDAC inhibitors nonspecifically target at least several of the 11 structurally similar but functionally different HDAC isozymes, which hampers their broad usage in clinical settings ...